Colorectal Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5473
|
1962
|
0.140 |
None |
0.857 |
7 |
2
|
2010 |
2019 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 3
|
phenotype |
|
Finding
|
165
|
368
|
0.100 |
None |
1.000 |
3 |
2
|
2010 |
2019 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 10
|
disease |
|
Finding
|
166
|
370
|
0.100 |
None |
1.000 |
3 |
2
|
2010 |
2019 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 12
|
disease |
|
Finding
|
166
|
373
|
0.100 |
None |
1.000 |
3 |
2
|
2010 |
2019 |
Colorectal Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1296
|
609
|
0.100 |
None |
1.000 |
3 |
2
|
2010 |
2019 |
Malignant tumor of colon
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
2969
|
688
|
0.100 |
None |
1.000 |
3 |
2
|
2010 |
2019 |
Malignant neoplasm of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
173
|
375
|
0.100 |
None |
1.000 |
3 |
2
|
2010 |
2019 |
Adenocarcinoma of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
543
|
432
|
0.100 |
None |
1.000 |
3 |
2
|
2010 |
2019 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 1
|
disease |
|
Finding
|
166
|
374
|
0.100 |
None |
1.000 |
3 |
2
|
2010 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2019 |
Secondary malignant neoplasm of liver
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
951
|
34
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2019 |
Asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
2096
|
1536
|
0.020 |
None |
1.000 |
2 |
|
2005 |
2019 |
Hematuria
|
phenotype |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
235
|
31
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Adenoma of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
452
|
213
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Tumour inflammation
|
disease |
|
Disease or Syndrome
|
24
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Nephrotic Syndrome
|
group |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
384
|
45
|
0.310 |
moderate |
1.000 |
1 |
|
2019 |
2019 |
Anti-Glomerular Basement Membrane Disease
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
32
|
3
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Glomerular Filtration Rate
|
phenotype |
|
Diagnostic Procedure
|
399
|
1033
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Tumor Angiogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
822
|
5
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Posterior Vitreous Detachment
|
disease |
Eye Diseases
|
Disease or Syndrome
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Ischemic stroke
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
1159
|
704
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Myasthenic Syndromes, Congenital
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
57
|
40
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Alport Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Skin and Connective Tissue Diseases; Male Urogenital Diseases
|
Disease or Syndrome
|
51
|
314
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Glioblastoma Multiforme
|
disease |
Neoplasms
|
Neoplastic Process
|
3197
|
186
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |